When compared with control mice, SHP2 inhibition resulted in a reduction in tumour growth and decreased Ki67 proliferation, which were associated with increased survival of II-B08-treated mice at 60 days post implantation of malignant U87 glioma cells. Here, PTPN11 is linked to neoplasm.